Catalytic activity of APOBEC3F is required for efficient restriction of Vif-deficient human immunodeficiency virus. - Wikidata - awgldk - TriplyDB

Catalytic activity of APOBEC3F is required for efficient restriction of Vif-deficient human immunodeficiency virus.

Catalytic activity of APOBEC3F is required for efficient restriction of Vif-deficient human immunodeficiency virus.

http://www.wikidata.org/entity/Q37599297

about

Suppression of APOBEC3-mediated restriction of HIV-1 by Vif 1.92 Angstrom Zinc-Free APOBEC3F Catalytic Domain Crystal Structure APOBEC3D and APOBEC3F potently promote HIV-1 diversification and evolution in humanized mouse model.APOBEC3G and APOBEC3F Act in Concert To Extinguish HIV-1 Replication APOBECs and virus restriction.Long-term passage of Vif-null HIV-1 in CD4+ T cells expressing sub-lethal levels of APOBEC proteins fails to develop APOBEC resistance.The in vitro Biochemical Characterization of an HIV-1 Restriction Factor APOBEC3F: Importance of Loop 7 on Both CD1 and CD2 for DNA Binding and Deamination.Influence of the DNA sequence/length and pH on deaminase activity, as well as the roles of the amino acid residues around the catalytic center of APOBEC3F.Multiple Inhibitory Factors Act in the Late Phase of HIV-1 Replication: a Systematic Review of the Literature.APOBEC3-mediated restriction of RNA virus replication.HIV-1 adaptation studies reveal a novel Env-mediated homeostasis mechanism for evading lethal hypermutation by APOBEC3G.

P2860

Q27025150-37DA6CF5-0EF6-450B-A4C2-227257638E31 Q27704805-5635F688-447B-4316-AA8A-03F4206CACD7 Q34352429-EB538605-2218-4B77-A726-61EF58B3519E Q36811931-A89D46F8-997C-4E40-902F-CBEB2C0634A1 Q38394187-1C3B1743-F62A-44C2-9BD0-32C267B73FB7 Q38719008-3C218457-5AA7-4F6F-8273-5533FB7E32AD Q40808215-CDD7F202-BA57-4298-A394-F0182F784EF7 Q41947706-8AD19D3B-FFFE-4BEC-B50A-9226175087A5 Q47555946-8E984DB0-C4FD-4DC6-AE24-F5D0D9BBBFA8 Q54236074-27D30928-AE97-4E7C-BC8F-0CBCEE7D282B Q55033661-99E4AABF-BEBF-432F-B6FB-52F9E35DF08E

P2860

Catalytic activity of APOBEC3F is required for efficient restriction of Vif-deficient human immunodeficiency virus.

http://www.wikidata.org/entity/Q37599297

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 20 December 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Catalytic activity of APOBEC3F ...... human immunodeficiency virus.

@en

Catalytic activity of APOBEC3F ...... human immunodeficiency virus.

@nl

type

label

Catalytic activity of APOBEC3F ...... human immunodeficiency virus.

@en

Catalytic activity of APOBEC3F ...... human immunodeficiency virus.

@nl

prefLabel

Catalytic activity of APOBEC3F ...... human immunodeficiency virus.

@en

Catalytic activity of APOBEC3F ...... human immunodeficiency virus.

@nl

P1433

Q37599297-8DBA373B-3B54-481F-BDA8-167432CDC15A

P1476

Q37599297-C36DE3C2-9AAD-47AD-B113-A6217A4E94B2

P2093

Q37599297-418923B7-0B48-442A-BA9C-A8D643A653D4

Q37599297-D4D2892E-C4B4-4E34-9C47-2EAA5AF9B5E3

P2860

Q37599297-01369BF4-FA6D-467E-9083-7D8B78D49BC8

Q37599297-01A38A43-0C03-48D5-9462-939F45C9BD91

Q37599297-01FA4C0F-C423-4897-A867-72883D32F5AA

Q37599297-0535AEC4-6F0F-4485-BCFB-D636EB1505C3

Q37599297-0648078D-C1CA-40FB-8741-C74DE515E26A

Q37599297-06AD8649-E13C-4C5D-A800-CE4C2FDBBEA3

Q37599297-0F15F2EE-7154-452E-A15F-6E2FA201D171

Q37599297-19075B14-5D97-4A84-8D72-6C7697788A2F

Q37599297-27AF4630-D396-4BCA-8329-FBA14F492013

Q37599297-2F795726-E54B-4E10-9652-43CEBCB5F1A1

P304

Q37599297-58724283-3A74-451C-A174-8D7BB640D449

P31

Q37599297-C077361B-7B4B-483F-9DCE-B4006EAF073E

P356

Q37599297-900556FD-C0B3-46A2-B1AE-6C325441CD3E

P407

Q37599297-9FDFE4A7-6EBE-4023-BCF7-699E45C62732

P478

Q37599297-87641D3C-40FC-4E29-AD09-83DDB66A76A1

P50

Q37599297-44D1A1BB-80AB-43E0-9A73-BA4001D1E63A

P577

Q37599297-D8596D31-3C1F-4E11-8674-809D58429856

P5875

Q37599297-92F9E815-14B3-4D89-89D2-F9453A822E8B

P698

Q37599297-D82ACE2F-A229-4309-9D5B-B30401EFD493

P932

Q37599297-DF666B95-226A-4E21-875F-A7BE1911D500

P356

J.VIROL.2013.11.041

P1433

P1476

Catalytic activity of APOBEC3F ...... human immunodeficiency virus.

@en

P2093

John S Albin

http://www.w3.org/2001/XMLSchema#string

William L Brown

http://www.w3.org/2001/XMLSchema#string

P2860

The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA

APOBEC3F can inhibit the accumulation of HIV-1 reverse transcription products in the absence of hypermutation. Comparisons with APOBEC3G

Human and rhesus APOBEC3D, APOBEC3F, APOBEC3G, and APOBEC3H demonstrate a conserved capacity to restrict Vif-deficient HIV-1

Differential requirement for conserved tryptophans in human immunodeficiency virus type 1 Vif for the selective suppression of APOBEC3G and APOBEC3F.

Inhibition of tRNA₃(Lys)-primed reverse transcription by human APOBEC3G during human immunodeficiency virus type 1 replication

Human immunodeficiency virus type 1 cDNAs produced in the presence of APOBEC3G exhibit defects in plus-strand DNA transfer and integration

Natural variation in Vif: differential impact on APOBEC3G/3F and a potential role in HIV-1 diversification

The APOBEC3 family of retroelement restriction factors

Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts

DNA deamination mediates innate immunity to retroviral infection

P304

49-54

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.VIROL.2013.11.041

http://www.w3.org/2001/XMLSchema#string

P407

P478

450-451

http://www.w3.org/2001/XMLSchema#string

P50

Reuben S Harris

P577

2013-12-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

259508261

http://www.w3.org/2001/XMLSchema#string

P698

24503066

http://www.w3.org/2001/XMLSchema#string

P932

3932626

http://www.w3.org/2001/XMLSchema#string